Keyword Analysis & Research: nikiforow
Keyword Research: People who searched nikiforow also searched
Search Results related to nikiforow on Search Engine
-
Sarah Nikiforow, MD, PhD - Dana-Farber Cancer Institute
https://www.dana-farber.org/find-a-doctor/sarah-nikiforow
WEBAssistant Professor of Medicine, Harvard Medical School. Centers/Programs. Hematologic Oncology. Stem Cell Transplantation. Clinical Interests. Adoptive cellular therapy, CAR T-cell therapy, Stem cell/bone marrow transplant. Diseases Treated. Allogeneic Stem Cell Transplant. Board Certification. Hematology, 2014. Internal Medicine, 2008.
DA: 75 PA: 15 MOZ Rank: 44
-
Sarah Nikiforow, MD - Brigham and Women's Hospital
https://physiciandirectory.brighamandwomens.org/details/15700/sarah-nikiforow-medical_oncology-boston
WEBSarah Nikiforow, MD is affiliated with Brigham and Women's Hospital and specializes in Medical Oncology in Boston, MA and Boston, MA.
DA: 34 PA: 10 MOZ Rank: 78
-
Sarah Nikiforow, MD, PhD - Dana-Farber Cancer Institute
https://providers.dana-farberbrigham.org/details/30142/sarah-nikiforow-boston
WEBDiseases Treated Adults. Allogeneic Stem Cell Transplant. Sarah Nikiforow, MD, PhD is affiliated with Dana-Farber Cancer Institute and specializes in Medical Oncology in Boston, MA.
DA: 20 PA: 74 MOZ Rank: 35
-
Dr. Sarah Nikiforow, MD - Hematology Specialist in Boston, MA
https://www.healthgrades.com/physician/dr-sarah-nikiforow-yn9lm
WEBDr. Sarah Nikiforow, MD is a hematology specialist in Boston, MA and has over 18 years of experience in the medical field. She graduated from Yale School of Medicine in 2005. She is affiliated with medical facilities such as Brigham And Women's Hospital and Cleveland Clinic Indian River Hospital.
DA: 39 PA: 95 MOZ Rank: 41
-
Exploring How CAR T-Cell Therapy May Help More Patients
https://www.dana-farber.org/newsroom/features/exploring-how-car-t-cell-therapy-may-help-more-patients
WEBDec 13, 2023 · Nikiforow is especially excited about bringing different types of cell therapy to even more solid tumor patients. "What I envision over the next 1-2 years are huge steps forward in both efficacy and safety across multiple diseases [with CAR T-cell therapy]," Nikiforow says.
DA: 16 PA: 71 MOZ Rank: 39
-
Dr. Sarah Nikiforow, MD, Oncology | Boston, MA | WebMD
https://doctor.webmd.com/doctor/sarah-nikiforow-fb338511-7622-418a-b265-183f8b3fb6b7-overview
WEBDr. Sarah Nikiforow, MD, is an Oncology specialist practicing in Boston, MA with 19 years of experience. This provider currently accepts 52 insurance plans including Medicare and Medicaid. New...
DA: 51 PA: 30 MOZ Rank: 56
-
Dr. Sarah Nikiforow, MD | Boston, MA | Oncologist | US News …
https://health.usnews.com/doctors/sarah-nikiforow-621270
WEBLiving Well With. Dr. Sarah Nikiforow is a Oncologist in Boston, MA. Find Dr. Nikiforow's phone number, address, insurance information, hospital affiliations and more.
DA: 91 PA: 79 MOZ Rank: 25
-
Sarah Nikiforow Bio | American Association for Cancer Research
https://aacrjournals.org/pages/sarah-nikiforow-bio
WEBSarah Nikiforow. Title & Affiliation: Assistant Professor, Stem Cell Transplantation Program; Assistant Medical Director, Cell Manipulation Core Facility, Attending Physician, Harvard Medical School. Boston, Massachusetts. Most-cited Article: Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and …
DA: 67 PA: 68 MOZ Rank: 7
-
Dr. Sarah Nikiforow - Boston MA, Medical Oncology, 450 …
https://www.healthcare6.com/physician/boston-ma/sarah-nikiforow-924252.html
WEBAug 5, 2011 · Dr. Sarah Nikiforow - Boston MA, Medical Oncology at 450 Brookline Ave Dana Farber Cancer Center - Smith 353. Phone: (617) 632-3779,(617) 632-3000. View info, ratings, reviews, specialties, education history, and more.
DA: 91 PA: 61 MOZ Rank: 22
-
The Revolution Continues in Cellular Therapies | Dana-Farber …
https://www.dana-farber.org/newsroom/features/the-revolution-continues-in-cellular-therapies
WEBApr 15, 2021 · Sarah Nikiforow, MD, PhD. Cell Therapy Adds a New Option to Cancer Treatment. Cell therapy is often said to be a new, "fifth pillar" of cancer treatment — joining surgery, radiation therapy, chemotherapy, and targeted therapy in the cancer armamentarium — but it actually represents a more fundamental change.
DA: 18 PA: 15 MOZ Rank: 77
